However, this doesn't mean you can't have strong opinions about certain investments. I'm quite confident that some stocks will be winners over the long run. Here are my three highest-conviction growth ...
Cannabix Technologies Inc. (the "Company" or "Cannabix") developer of marijuana and alcohol breath testing devices is pleased to report that it has made significant updates to its Cannabix Marijuana ...
EyePoint Pharmaceuticals, Inc. has appointed Dr. Reginald J. Sanders, a prominent ophthalmologist and former president of the American Society of Retina Specialists, to its Board of Directors.
Vertex Pharmaceuticals Incorporated (Nasdaq ... for the treatment of CF,” said Claire L. Keating, M.D., Co-Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program at Columbia ...
If that trend continues, it's unlikely the consumer staples, energy, real estate, healthcare, or materials sectors will beat ...
Royalty Pharma plc to become an integrated company by acquiring its external manager, RP Management, LLC <li /> <str ...
NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ordinary share, ...
Enzon Pharmaceuticals has expanded its Board of Directors to four members and appointed Stephen T. Wills as a new director. Wills brings extensive experience from his roles at various ...
EyePoint Pharmaceuticals announced the appointment of Dr. Reginald J. Sanders, a renowned retina specialist and leader in ophthalmology, to its Board of Directors. This strategic addition is ...
Pets can encounter a multitude of potential toxins every day, but the toxicology experts at Pet Poison Helpline have released their annual list of the Top10 Pet Poisons of 2024 based on actual caller ...
EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), a biopharmaceutical company focused on developing treatments for serious retinal diseases, announced today the appointment of Reginald J. Sanders, ...
October 29, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that the Company’s board of directors has determined that an unsolicited and non ...